{"id":10144,"date":"2018-04-06T21:02:37","date_gmt":"2018-04-06T19:02:37","guid":{"rendered":"http:\/\/okomeds.com\/?p=10144\/"},"modified":"2019-09-10T10:05:57","modified_gmt":"2019-09-10T08:05:57","slug":"clinical-research-translation-news-april-cro-special","status":"publish","type":"post","link":"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/","title":{"rendered":"Clinical Research Translation News April (CRO Special)"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_81 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenidos\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#IMPORTANT_LAW_CHANGES_AFFECTING_CROs\" >IMPORTANT LAW CHANGES AFFECTING CROs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CRO_TENDENCIES\" >CRO TENDENCIES<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CROs_MERGERS_ACQUISITIONS\" >CROs \u00a0MERGERS &amp; ACQUISITIONS<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#Some_CRO_MERGERS_data\" >Some CRO MERGERS data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#Some_CRO_ACQUISITIONS_data\" >Some CRO ACQUISITIONS data<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CRO_PROJECT_SELECTION\" >CRO PROJECT SELECTION<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CRO_POSITIONING_AND_EXPANSION\" >CRO POSITIONING AND EXPANSION<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CROs_COST_REDUCTION\" >CROs &amp; COST REDUCTION<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CRO_AWARDS\" >CRO AWARDS<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#CRO_MARKET_DATA\" >CRO MARKET DATA<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#1-_Key_CRO_players\" >1.- Key CRO players<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#2-_Main_geographic_regions\" >2.-\u00a0 Main geographic regions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#3-_CROs_Market_segments\" >3.- CROs Market segments<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/okomeds.com\/es\/clinical-research-translation-news-april-cro-special\/#4-_CROs_Market_services\" >4.- CROs Market services<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"IMPORTANT_LAW_CHANGES_AFFECTING_CROs\"><\/span>IMPORTANT LAW CHANGES AFFECTING CROs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li>From 11 May, 2017, significant changes for drug development in China are taking place encouraging a new era for device, drug development and medical translation for CROs.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRO_TENDENCIES\"><\/span>CRO TENDENCIES<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p>As competition within the drug development landscape intensifies and <a href=\"http:\/\/okomeds.com\/health-medicine-and-medical-translation-services-december-news\/\" target=\"_blank\" rel=\"noopener\">clinical trial <\/a>protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices, including translation for CROs, to both ensuring trial success and making sure patients remain the center of the processes.<\/p>\n<p>Contract Research Organizations (CROs) and clinical investigative sites are increasingly adopting a patient-centric approach to trial design to address some of the challenges inherent in clinical research. This should be specially taken into consideration as regards clinical trials of rare diseases, where the eligible patient population is limited.<\/p>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CROs_MERGERS_ACQUISITIONS\"><\/span>CROs \u00a0MERGERS &amp; ACQUISITIONS<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<p>CRO industry has been consolidating for years now, partially with the help of private equity. This consolidation includes new service offerings, new Translation for CROs needs, formal strategic partnerships and manufacturing deals.<\/p>\n<p>However, mergers and acquisitions have been very active lately.<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Some_CRO_MERGERS_data\"><\/span>Some CRO MERGERS data<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li>Merger agreement between Fagron &amp; Humco\u00a0for up to $70 million.<\/li>\n<li>Syneos Health aims to establish new industry standards to improve clinical trial collaboration and execution by joining Align Clinical CRO.<\/li>\n<li>Leadership award winner PPD expands GMP Biologics Testing Capacity.<\/li>\n<li>Merger between 2 CROs, Linical and Accelovance to boost their oncology expertise. Probably new translation for CROs services might be required.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Some_CRO_ACQUISITIONS_data\"><\/span>Some CRO ACQUISITIONS data<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li>George Clinical expands its operational expertise throughout the United States. A leading full-service CRO in the Asia-Pacific region, George Clinical, is acquired the CRO Division of the Memphis-based leader in oncology research and data analytics, Vector Oncology.<\/li>\n<li>The Sale of Parexel appears to be good news for the CRO industry, which is seen as attractive because drug companies increasingly are outsourcing their <a href=\"http:\/\/okomeds.com\/medical-records-translation-services-life-expectancy-and-longevity\/\" target=\"_blank\" rel=\"noopener\">clinical trial efforts as well as translation requirements.<\/a><\/li>\n<li>ICON plc, will rebrand their acquired ClinicalRM division into ICON Government and Public Health Solutions, which demonstrates ICON\u2019s commitment to solving global health issues through enhancing capabilities in vaccines and infectious diseases.<\/li>\n<li>Tergus Pharma\u00a0has acquired\u00a0a Dermatology-centric CRO based in Kannapolis, NC, EnDev Laboratories,which will add extensive early-phase drug development capabilities from lead compound selection to skin biology. New translation for CROs services might also be demanded.<\/li>\n<li>Roche acquires Flatiron Health, a market leader in oncology-specific <a href=\"http:\/\/okomeds.com\/translation-localization-medical-software\/\" target=\"_blank\" rel=\"noopener\">electronic health record software<\/a> and a privately held healthcare technology and services company headquartered in New York City, US. It will be essential to contract the adequate <a href=\"http:\/\/okomeds.com\/translation-cro\/\" target=\"_blank\" rel=\"noopener\">translation for CROs<\/a> services.<\/li>\n<li>Concord Biosciences acquired by Frontage Laboratories.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n\r\n        <a href=\"https:\/\/twitter.com\/intent\/tweet?text=Did you know that CROs play a key part in improving the lives of thousands of people?&url=&via=okomeds\" class=\"retweet-okodia\" >Did you know that CROs play a key part in improving the lives of thousands of people? <div class=\"retwitear-ok\" style=\"text-align: right;   font-size: 10px; padding-right: 43px;\">Tweet!<\/div><\/a>\r\n        <script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0];if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=\"\/\/platform.twitter.com\/widgets.js\";fjs.parentNode.insertBefore(js,fjs);}}(document,\"script\",\"twitter-wjs\");<\/script>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRO_PROJECT_SELECTION\"><\/span>CRO PROJECT SELECTION<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li>NurOwn has selected Leadership award winner Worldwide Clinical Trials\u00a0CRO to run\u00a0a Phase 3 study\u00a0for the treatment of amyotrophic lateral sclerosis based on the investigational stem-cell therapy. The study will be carried out in US and Israel. If translation for CROs services are not already commited, we recomend Okomeds&#8217;.<\/li>\n<li>Incyte, Merck and KEYTRUDA, working for patients with Metastatic or unresectable Melanoma.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRO_POSITIONING_AND_EXPANSION\"><\/span>CRO POSITIONING AND EXPANSION<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li>ZEINCRO has been reinforcing, during the last years its leading position in Central- and South- Eastern Europe following a need to establish local presence strategy.<\/li>\n<li>George Clinical, has not only been reinforcing its position in the Asia-Pacific region, but spanding to the United States.<\/li>\n<li>The Venture capital firm ShangPharma wants to stretch out by 40% in the Bay Area, with extra lab infrastructure and conferencing space.<\/li>\n<li>Okomeds is expanding and currently incresing its translation for CROs services.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CROs_COST_REDUCTION\"><\/span>CROs &amp; COST REDUCTION<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li>How to <a href=\"http:\/\/okomeds.com\/translating-clinical-trial-protocols\/\" target=\"_blank\" rel=\"noopener\">make clinical trials more efficient<\/a> and to drive down drug development costs is Mitsubishi Tanabe\u2019s motto and aim while applying Hitachi\u2019s artificial intelligence technology.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRO_AWARDS\"><\/span>CRO AWARDS<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<ul>\n<li>Domainex was awarded \u00a3118,000 from the UK\u2019s innovation agency to develop a new biophysical screening method for G-protein coupled receptors.<\/li>\n<li>2017 CRO Leadership awards winners are: Algorithme Pharma, Celerion, Chiltern, Covance Inc., DaVita Clinical Research (DCR), Duke Clinical Research Institute, Eurofins Scientific, INC Research, inVentiv Health, NAMSA, Pharm-Olam International, PPD, QPS Holdings, Rho, SGS Life Sciences, UBC, Vince &amp; Associates Clinical Research, Worldwide Clinical Trials.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CRO_MARKET_DATA\"><\/span><strong>CRO MARKET DATA<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1-_Key_CRO_players\"><\/span>1.- Key CRO players<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<p>IQVIA, PAREXEL, LabCorp, Syneos Health, Charles River Laboratories, PRA Health Sciences, WuXi Pharmatech, ICON plc, Development of pharmaceutical products, MedPace Holdings, Chiltern International Ltd. and Clintract, Inc.\u00a0Some of which are already <a href=\"http:\/\/okomeds.com\/clients\/\" target=\"_blank\" rel=\"noopener\">Okomeds&#8217; clients.<\/a><\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2-_Main_geographic_regions\"><\/span>2.-\u00a0 Main geographic regions<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<p>US, China, EU, Southeast Asia and India.<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3-_CROs_Market_segments\"><\/span>3.- CROs Market segments<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<p>Academic institutes, <a href=\"http:\/\/okomeds.com\/pharmaceutical-translation\/\" target=\"_blank\" rel=\"noopener\">pharmaceutical and biopharmaceutical companies<\/a> and medical device companies.<\/p>\n<p>&nbsp;<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4-_CROs_Market_services\"><\/span>4.- CROs Market services<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>&nbsp;<\/p>\n<p>Laboratory services, early phase development services, toxicology tests, pharmacokinetics, pharmacodynamics, clinical research services and others.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IMPORTANT LAW CHANGES AFFECTING CROs &nbsp; From 11 May, 2017, significant changes for drug development in China are taking place encouraging a new era for device, drug development and medical translation for CROs. &nbsp; CRO TENDENCIES &nbsp; As competition within the drug development landscape intensifies&#8230;<\/p>\n","protected":false},"author":1,"featured_media":10146,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5,6],"tags":[194,197,189,192,195,190,196,198,199,200,191,36,204,203,201,202,15,13,12,193,49,205],"class_list":["post-10144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-research","category-medical-translations","tag-adqusitions","tag-award","tag-clinical-research-translation","tag-clinical-trials","tag-cost-reduction","tag-cro","tag-cro-awrds","tag-cro-expansion","tag-cro-positioning","tag-cro-tendencies","tag-cros","tag-drugs","tag-geographic-regions","tag-key-players","tag-market-segments","tag-market-services","tag-medical-translation","tag-medical-translation-agency","tag-medical-translations","tag-mergers","tag-multiple-sclerosis","tag-translation-for-cros"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Research Translation News April (CRO Special)<\/title>\n<meta name=\"description\" content=\"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Research Translation News April (CRO Special)\" \/>\n<meta property=\"og:description\" content=\"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\" \/>\n<meta property=\"og:site_name\" content=\"Okomeds\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/okomeds\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-06T19:02:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-10T08:05:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"626\" \/>\n\t<meta property=\"og:image:height\" content=\"410\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@okomeds\" \/>\n<meta name=\"twitter:site\" content=\"@okomeds\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/okomeds.com\/#\/schema\/person\/5062c4cf21c1f2dca57a0b960e23a24f\"},\"headline\":\"Clinical Research Translation News April (CRO Special)\",\"datePublished\":\"2018-04-06T19:02:37+00:00\",\"dateModified\":\"2019-09-10T08:05:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\"},\"wordCount\":790,\"publisher\":{\"@id\":\"https:\/\/okomeds.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg\",\"keywords\":[\"adqusitions\",\"award\",\"clinical research translation\",\"clinical trials\",\"cost reduction\",\"CRO\",\"cro awrds\",\"cro expansion\",\"cro positioning\",\"cro tendencies\",\"CROs\",\"drugs\",\"geographic regions\",\"key players\",\"market segments\",\"market services\",\"medical translation\",\"medical translation agency\",\"medical translations\",\"mergers\",\"MULTIPLE SCLEROSIS\",\"translation for CROs\"],\"articleSection\":[\"Clinical Research\",\"Medical translations\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\",\"url\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\",\"name\":\"Clinical Research Translation News April (CRO Special)\",\"isPartOf\":{\"@id\":\"https:\/\/okomeds.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg\",\"datePublished\":\"2018-04-06T19:02:37+00:00\",\"dateModified\":\"2019-09-10T08:05:57+00:00\",\"description\":\"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...\",\"breadcrumb\":{\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage\",\"url\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg\",\"contentUrl\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg\",\"width\":626,\"height\":410,\"caption\":\"Clinical Research Translation News April. CRO Special\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/okomeds.com\/es\/inicio-2-2\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Research Translation News April (CRO Special)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/okomeds.com\/#website\",\"url\":\"https:\/\/okomeds.com\/\",\"name\":\"Okomeds\",\"description\":\"Agencia de traducci\u00f3n m\u00e9dica y de salud\",\"publisher\":{\"@id\":\"https:\/\/okomeds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/okomeds.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/okomeds.com\/#organization\",\"name\":\"Okodia\",\"url\":\"https:\/\/okomeds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/okomeds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2015\/12\/logo-okomeds.png\",\"contentUrl\":\"https:\/\/okomeds.com\/wp-content\/uploads\/2015\/12\/logo-okomeds.png\",\"width\":300,\"height\":77,\"caption\":\"Okodia\"},\"image\":{\"@id\":\"https:\/\/okomeds.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/okomeds\",\"https:\/\/x.com\/okomeds\",\"https:\/\/www.linkedin.com\/company\/okomeds\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/okomeds.com\/#\/schema\/person\/5062c4cf21c1f2dca57a0b960e23a24f\",\"name\":\"admin\",\"url\":\"https:\/\/okomeds.com\/es\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Research Translation News April (CRO Special)","description":"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/","og_locale":"es_ES","og_type":"article","og_title":"Clinical Research Translation News April (CRO Special)","og_description":"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...","og_url":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/","og_site_name":"Okomeds","article_publisher":"https:\/\/www.facebook.com\/okomeds","article_published_time":"2018-04-06T19:02:37+00:00","article_modified_time":"2019-09-10T08:05:57+00:00","og_image":[{"width":626,"height":410,"url":"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@okomeds","twitter_site":"@okomeds","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#article","isPartOf":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/"},"author":{"name":"admin","@id":"https:\/\/okomeds.com\/#\/schema\/person\/5062c4cf21c1f2dca57a0b960e23a24f"},"headline":"Clinical Research Translation News April (CRO Special)","datePublished":"2018-04-06T19:02:37+00:00","dateModified":"2019-09-10T08:05:57+00:00","mainEntityOfPage":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/"},"wordCount":790,"publisher":{"@id":"https:\/\/okomeds.com\/#organization"},"image":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage"},"thumbnailUrl":"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg","keywords":["adqusitions","award","clinical research translation","clinical trials","cost reduction","CRO","cro awrds","cro expansion","cro positioning","cro tendencies","CROs","drugs","geographic regions","key players","market segments","market services","medical translation","medical translation agency","medical translations","mergers","MULTIPLE SCLEROSIS","translation for CROs"],"articleSection":["Clinical Research","Medical translations"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/","url":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/","name":"Clinical Research Translation News April (CRO Special)","isPartOf":{"@id":"https:\/\/okomeds.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage"},"image":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage"},"thumbnailUrl":"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg","datePublished":"2018-04-06T19:02:37+00:00","dateModified":"2019-09-10T08:05:57+00:00","description":"As competition within the drug development landscape intensifies and clinical trial protocols become more complex, the industry is refocusing the needs and experience of clinical research patients developing best practices...","breadcrumb":{"@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#primaryimage","url":"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg","contentUrl":"https:\/\/okomeds.com\/wp-content\/uploads\/2018\/04\/scientist-man_1368-4773.jpg","width":626,"height":410,"caption":"Clinical Research Translation News April. CRO Special"},{"@type":"BreadcrumbList","@id":"https:\/\/okomeds.com\/clinical-research-translation-news-april-cro-special\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okomeds.com\/es\/inicio-2-2\/"},{"@type":"ListItem","position":2,"name":"Clinical Research Translation News April (CRO Special)"}]},{"@type":"WebSite","@id":"https:\/\/okomeds.com\/#website","url":"https:\/\/okomeds.com\/","name":"Okomeds","description":"Agencia de traducci\u00f3n m\u00e9dica y de salud","publisher":{"@id":"https:\/\/okomeds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okomeds.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/okomeds.com\/#organization","name":"Okodia","url":"https:\/\/okomeds.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/okomeds.com\/#\/schema\/logo\/image\/","url":"https:\/\/okomeds.com\/wp-content\/uploads\/2015\/12\/logo-okomeds.png","contentUrl":"https:\/\/okomeds.com\/wp-content\/uploads\/2015\/12\/logo-okomeds.png","width":300,"height":77,"caption":"Okodia"},"image":{"@id":"https:\/\/okomeds.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/okomeds","https:\/\/x.com\/okomeds","https:\/\/www.linkedin.com\/company\/okomeds"]},{"@type":"Person","@id":"https:\/\/okomeds.com\/#\/schema\/person\/5062c4cf21c1f2dca57a0b960e23a24f","name":"admin","url":"https:\/\/okomeds.com\/es\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/posts\/10144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/comments?post=10144"}],"version-history":[{"count":10,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/posts\/10144\/revisions"}],"predecessor-version":[{"id":10157,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/posts\/10144\/revisions\/10157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/media\/10146"}],"wp:attachment":[{"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/media?parent=10144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/categories?post=10144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/okomeds.com\/es\/wp-json\/wp\/v2\/tags?post=10144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}